Study of Pre-operative Combination Therapy With Mogamulizumab and Nivolumab Against Solid Cancer Patients

NCT02946671 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer
Esophageal Cancer
Lung Cancer
Renal Cancer
Oral Cancer

Interventions

BIOLOGICAL: Mogamulizumab
BIOLOGICAL: Nivolumab

Sponsor

Osaka University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]